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Abstract
This is a prospective study to establish prediction models that map the refined Scoliosis
Research Society 22-item (SRS-22r) onto EuroQoL-5 dimension 5-level (EQ-5D-5L) utility
scores in adolescent idiopathic scoliosis (AIS) patients. Comparison of treatment outcomes
in AIS can be determined by cost-utility analysis. However, the mainstay spine-specific
health-related quality of life outcome measure, the SRS-22r questionnaire does not provide
utility assessment. In this study, AIS patients were prospectively recruited to complete both
the EQ-5D-5L and SRS-22r questionnaires by trained interviewers. Ordinary least squares
regression was undertaken to develop mapping models, which the validity and robustness
were assessed by using the 10-fold cross-validation procedure. EQ-5D-5L utility scores
were regressed on demographics, Cobb angle, curve types, treatment modalities, and five
domains of the SRS-22r questionnaire. Three models were developed using stepwise selec-
tion method. EQ-5D-5L scores were regressed on 1) main effects of SRS-22r subscale
scores, 2) as per 1 plus squared and interaction terms, and 3) as per 2 plus demographic
and clinical characteristics. Model goodness-of-fit was assessed using R-square, adjusted
R-square, and information criteria; whereas the predictive performance was evaluated using
root mean square error (RMSE), mean absolute error (MAE), and the proportion of absolute
error within the threshold of 0.05 and 0.10. A total of 227 AIS patients with mean age of 15.6
years were recruited. The EQ-5D-5L scores were predicted by four domains of SRS-22r
(main effects of ‘Function’, ‘Pain’, ‘Appearance’ and ‘Mental Health’, and squared term of
‘Function’ and ‘Pain’), and Cobb angle in Model 3 with the best goodness-of-fit (R-square/
adjusted R-square: 62.1%/60.9%). Three models demonstrated an acceptance predictive
performance in error analysis applying 10-fold cross-validation to three models where RMSE
and MAE were between 0.063–0.065 and between 0.039–0.044, respectively. Model 3 was
therefore recommended out of three mapping models established in this paper. To our knowl-
edge, this is the first study to map a spine-specific health-related quality of life measure onto
EQ-5D-5L for AIS patients. With the consideration and incorporation of demographic and
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clinical characteristics, over 60% variance explained by mapping model 3 enabled the satis-
factory prediction of EQ-5D-5L utility scores from existing SRS-22r data for health economic
appraisal of different treatment options.
Introduction
Adolescent idiopathic scoliosis (AIS) is the most common form of scoliosis, representing
structural curves detected during adolescence without any clear underlying cause.[1] This type
of scoliosis accounts for, up to 80% of idiopathic scoliosis in the United States, in otherwise
healthy individuals undergoing puberty.[2] These patients often experience truncal imbalance,
cosmetic unsightliness and even back pain with associated reduction in physical and mental
health.[3–5] In severe cases, cardiopulmonary compromise may occur.[6, 7] These presenta-
tions in addition to curve progression may lead to a worsened impact on patients’ health-
related quality of life (HRQoL) as a whole. The latest version of Scoliosis Research Society
(SRS) instruments, the Refined Scoliosis Research Society 22-item (SRS-22r) questionnaire[8],
is adopted to capture the HRQoL of AIS patients. The SRS-22r has been shown as a valid and
reliable tool which has been used extensively over the past decade. From a recent systematic
review of studies reporting quality of life, the most frequently used instruments were Scoliosis
Research Society 22-item, 30-item and 24-item (SRS-22, SRS-30, SRS-24) questionnaires, con-
tributing to approximately three-fourth of the reviewed studies.[9]
For AIS management, bracing is usually offered for moderate-sized progressive curves and
surgery is offered for severe curvatures of over 40–45˚.[4, 10] With increased disease preva-
lence and economic burden imposed to the healthcare system, evidence regarding cost-utility
becomes an essential component for critical appraisal of available treatment options. Among
those with curves between 35˚ to 55˚, there is controversy upon which whether observation,
bracing or surgery is better indicated in the context of cost-utility or HRQoL.[11, 12] Differen-
tiating treatment options such as surgical approaches, implant strategy and instrumentation
systems with regards to cost-utility is also necessary. As such, little is known to elucidate the
health economic values of AIS treatment modalities.
As utility score data is an essential input for quality-adjusted life-years (QALYs) calculation
in cost-utility analysis,[13] there is a need to develop an algorithm that maps HRQoL scores
from scoliosis-specific instrument onto utility scores. Despite the good correlation between
SRS-22 and generic 36-Item Short Form Health Survey (SF-36) questionnaires, the existing
mapping model available for predicting SRS-22 subscale scores from SF-36 subscale scores for
AIS patients is in the mental health and pain domains only.[14] In search of a more appropri-
ate measure specifically for AIS, the EuroQol-5 Dimension (EQ-5D) utility score has been
used in all economic evaluation submitted to health technology assessment authorities such as
the National Institute for Health and Care Excellence (NICE) in UK.[15] This goes beyond
ethnic and cultural background as the EuroQol-5 Dimension 5-Level (EQ-5D-5L) utility score
has been shown to be a valid, reliable and sensitive measure to assess the HRQoL in southern
Chinese AIS patients. The EQ-5D-5L utility score showed good and significant correlations
with SRS-22r total and all domain scores except for Satisfaction with Management.[16] There-
fore this study aims to establish a prediction model that maps spine-specific scores represented
by the SRS-22r, onto the EQ-5D-5L utility scores in AIS patients, with adjustment for demo-
graphic and clinical characteristics. We hypothesized that the Satisfaction with Management
domain will not be significant predictor of the EQ-5D-5L score because such domain is not
conceptually included in any of the five domains of EQ-5D-5L.
Mapping the SRS-22r onto the EQ-5D-5L
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Materials and methods
Subjects
A prospective study with recruitment of southern Chinese AIS patients managed at a tertiary
referral center for scoliosis during the months of August to October 2015 was performed.
Exclusion criteria included patients with non-idiopathic scoliosis, those who could not under-
stand traditional Chinese, with intellectual/ physical disability, or refused to participate. Ethics
approval was obtained from the local Institutional Review Board of the University of Hong
Kong / Hospital Authority Hong Kong West Cluster (HKWC/HKU IRB). Written informed
consent was obtained from all recruited patients and the consent document was approved by
the ethics committee. The reporting of this mapping study complied with the Mapping onto
Preference-based measures reporting Standards (MAPS) statement.[17]
All eligible patients were approached by trained research personnel who distributed and
allowed self-completion of both the EQ-5D-5L (Hong Kong (traditional Chinese) EQ-5D-5L
Version 1.0, EuroQol)[18] and SRS-22r questionnaires.[19] To control for the ordering effect
of completing the questionnaire, half of the patients were provided with EQ-5D-5L followed
by SRS-22r, and the remaining half were given the questionnaires in the reversed order. All
questionnaires were completed by the patients themselves.
During the visit, patients’ consultation and radiographic examinations were performed as
usual. A spine surgeon measured the Cobb angle[20] on the standing whole spine posteroan-
terior radiograph taken at that appointment without any knowledge of this study. The curva-
tures were classified subsequently using the modified Lenke classification system,[21] which
included six curve types: type 1 (main thoracic), type 2 (double thoracic), type 3 (double
major; thoracic curve larger than lumbar curve), type 4 (triple major), type 5 (thoracolumbar
or lumbar curve), type 6 (double major; thoracolumbar or lumbar curve larger than thoracic
curve), and curvature magnitude (40˚ vs>40˚) was noted. Clinical parameters also included
treatment modalities of whether the patient had bracing or surgery, and the duration of brac-
ing (<1 year vs1 year) if applicable. Demographic data such as age and sex were collected.
Study instruments
Refined Scoliosis Research Society 22-item (SRS-22r). The SRS-22r questionnaire, a
refinement of the SRS-24 questionnaire, was a disease-specific instrument used routinely dur-
ing management of scoliosis patients. It had been previously validated in the Hong Kong Chi-
nese scoliosis population.[19] It contained 22 items contributing to five main domains:
Function (5 items), Pain (5 items), Self-image/appearance (5 items), Mental Health (5 items),
Satisfaction with Treatment (Current/Previously performed—2 items).
EuroQoL 5-dimension 5-level (EQ-5D-5L). The EQ-5D-5L is the latest version of the
EQ-5D multi-attribute health classification system for measuring HRQOL and utility scores,
consisting of five dimensions: mobility, self-care, usual activity, pain/discomfort and anxiety/
depression. Each dimension had five severity levels: no problem, mild problem, moderate
problems, severe problems, extreme problems. In principle, the utility scores are preference
weights measured on a cardinal scale of 0–1, where ‘0’ indicates death and 1 indicates perfect
health. Health states worse than death takes negative value of utility. Since the Chinese-specific
EQ-5D-5L value set was currently unavailable, the EQ-5D-5L utility score was not determined
through direct valuation of EQ-5D-5L health states. Rather, the two-step indirect approach
was applied in this study to estimate EQ-5D-5L values applicable for Chinese population, as
adopted in previous studies.[22, 23] The first step was the application of an indirect interim
mapping method from a six-country study coordinated by EuroQoL group.[24] The EQ-5D-
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5L health status was transformed to EQ-5D-3L health status following the transition probabili-
ties between the response patterns of EQ-5D-5L and EQ-5D-3L. Finally, EQ-5D-3L health sta-
tus were scored according to a recently developed Chinese-specific EQ-5D-3L value set
ranging from -0.149 for the worst health status (‘33333’) to 1 for the full health (‘11111’).[25]
Statistical analysis
Model specification. Three separate models (Table 1) mapping SRS-22r onto EQ-5D-5L
utility score were estimated by ordinary least squares (OLS) method. EQ-5D-5L scores were
regressed on 1) five main terms (Function / Pain / Appearance / Mental Health / Satisfaction
with Treatment) of SRS-22r subscale scores (Model 1), 2) as per 1 plus squared terms of sub-
scale scores selected in Model 1 (Model 2), and 3) as per 2 plus demographic and clinical char-
acteristics such as Cobb angle and treatment modalities (Model 3). Squared terms were added
to the mapping function to account for possible non-linear association between SRS-22r and
EQ-5D-5L utility score. The OLS method was the commonest estimation method, accounting
for 80% of studies mapping HRQOL scores onto EQ-5D scores[26]. Backward stepwise selec-
tion approach was used to select an array of variables in each model. The F-test was used to
retain variables with an exclusion criterion of P-value greater than 0.10. There was a total of
three mapping models developed for researchers to decide which mapping model was chosen
depending upon the availability of demographic and clinical data.
Model validation and comparison. Model validation of three mapping functions were
assessed by using the 10-fold cross-validation procedure.[27, 28] In brief, our sample is ran-
domly partitioned into 10 equally sized subsamples. Of the 10 subsamples, one subsample and
nine remaining subsamples were used as training and validation data, respectively. The cross-
validation procedure was repeated 10 times with each of the nine subsamples (204–205 sam-
ples each) used once as the validation data. The model parameters, goodness-of-fit and predic-
tive performances from the 10 folds were averaged to produce a single estimation.
Model goodness-of-fit was assessed using R-square, adjusted R-square, Akaike information
criteria (AIC), and Bayesian information criteria (BIC) statistics. A better model goodness-of-
fit was indicated if the R-square and adjusted R-square were higher; and the AIC and BIC val-
ues were lower. To assess the predictive performance of models, the differences between the
predicted and observed EQ-5D-5L scores at individual level were examined by computing
root mean square error (RMSE) and mean absolute error (MAE). The number of observations
and the corresponding proportions in the sample where the absolute error (AE) was greater
than 0.05 and 0.10, respectively, were calculated. The ranges of the achievable EQ-5D-5L
scores from the resulting mapping models were compared with the theoretical range of the
EQ-5D-5L scores computed according to Chinese-specific tariff.
All statistical analyses were conducted using the STATA software (StataCorp LP, College
Station, Tex) version 13.0.
Table 1. Mapping models for EQ-5D-5L scores predicting from SRS-22r domain scores.
Model Independent Variables Estimation
1 SRS-22r Domain scores (Main effects) OLS
2 SRS-22r Domain scores (Main effects and squared terms) OLS
3 SRS-22r Domain scores (Main effects and squared terms); Clinical and demographic
characteristics
OLS
Note: EQ-5D-5L = EuroQoL 5-dimension 5-level; SRS-22r = Refined Scoliosis Research Society-22;
OLS = Ordinary Least Squares
https://doi.org/10.1371/journal.pone.0175847.t001
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Results
A total of 227 AIS patients were recruited. A majority of patients were female (75%), with a
mean age of 15.6 years (standard deviation (SD): 4.5). 33.1% of this studied population were
undergoing bracing or had corrective surgery performed. The mean Cobb angle was 25.0
degrees (SD: 11.4 degrees) at recruitment (Table 2). Descriptive statistics of EQ-5D-5L utility
scores and SRS-22r domain scores were found in Table 3. The mean EQ-5D-5L utility scores
was 0.931 (SD: 0.113; range: 0.339–1.000).
The OLS regression analysis of the models and those validation results were shown in
Table 4 and Table 5, respectively. Main effects of five domain scores of SRS-22r were the pre-
dictors of the first model (model 1) but ‘Satisfaction’ domain score was dropped due to statisti-
cal insignificance (P-value>0.01). In model 2, the squared terms of four remaining domains
were added for consideration but only the squared term of ‘Function/activity’ and ‘Pain’
domain scores (P-value = 0.041; P-value = 0.022) remained significant during the stepwise
selection procedure. Cobb angle at recruitment (P-value<0.01) were retained in model 3 when
adjusting for all demographic and clinical characteristics. By using ordinary least square esti-
mation with clinical and demographic characteristics, EQ-5D-5L score was regressed on SRS-
22r Domain scores with detailed formula equation of the selected model 3 found as expressed
below:
Predicted EQ   5D   5L score ¼
  0:366þ 0:489 x ðFunction = activityÞ   0:042 x ðFunction = activityÞ2   0:221 x ðPainÞ þ 0:031 x ðPainÞ2
þ0:023 x ðAppearanceÞ þ 0:037 x ðMental HealthÞ þ 0:001 x ðCobb angleÞ
Model 2 and 3 got R-square of 60% or above, demonstrating acceptable goodness-of-fit.
The R-square, adjusted R-square, AIC and BIC values were further improved and optimized
Table 2. Descriptive statistics of demographic and clinical characteristics.
Overall (n = 227)
Age (years, Mean±SD) 15.5 ± 3.8
Sex
Male 57 (25.1%)
Female 170 (74.9%)
Cobb angle (degree, Mean±SD) 23.9 ± 10.3
40˚, Mild or moderate 205 (90.3%)
>40˚, Severe 22 (9.7%)
Treatment modality
Wearing bracing 54 (23.8%)
Surgery 21 (9.3%)
Duration of Bracing
<1 year 20 (37.0%)
1 year 34 (63.0%)
Modified Lenke Classification
Thoracic curve (Types 1/2) 86 (37.9%)
Lumbar curve (Type 5) 38 (16.7%)
Thoracic & Lumbar curve (Types 3/4/6) 103 (45.4%)
Note: SD = standard deviation
https://doi.org/10.1371/journal.pone.0175847.t002
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with adjustment of patients’ characteristics. Model 3 had better goodness-of-fit than Model 1
and 2. Predictive performance was considered good according to the error analysis and excel-
lent values as expressed in terms of RMSE and MAE (Table 4). The scatterplot of observed
and predicted EQ-5D-5L scores by mapping function was shown in Fig 1. A pattern of overes-
timation was recognized for observed scores lower than 0.8, whereas underestimation was
Table 3. Descriptive statistics of EuroQoL 5-dimension 5-level (EQ-5D-5L) scores and refined scoliosis research Society-22 (SRS-22r) domain
scores.
Overall (n = 227)
Theoretical Range Mean ± SD 95% C.I. Observed Range
Utility Scores
EQ-5D-5L score -0.149–1.000 0.931 ± 0.113 0.909–0.954 0.339–1.000
SRS-22 Domain
Function/activity 1.0–5.0 4.774 ± 0.421 4.692–4.857 2.6–5.0
Pain 1.0–5.0 4.667 ± 0.441 4.580–4.753 1.8–5.0
Appearance 1.0–5.0 3.935 ± 0.641 3.809–4.061 2.0–5.0
Mental Health 1.0–5.0 4.420 ± 0.584 4.306–4.534 2.6–5.0
Satisfaction with management 0.0–5.0 1.069 ± 1.805 0.715–1.423 0.0–5.0
Note: SD = standard deviation; C.I. = Confidence Interval
https://doi.org/10.1371/journal.pone.0175847.t003
Table 4. Mapping models for patients with adolescent idiopathic scoliosis using main effects, squared terms of SRS-22r and patients’
characteristics.
Mapping Model (n = 227)
Main effects
Model 1
Squared terms added
Model 2
Clinical and demographic
characteristics added
Model 3
SRS-22r Domain Coeff. (95% C.I) Coeff. (95% C.I) Coeff. (95% C.I)
Constant -0.094 (-0.212,0.023) -0.474 (-1.158,0.210) -0.366 (-1.040,0.308)
Function / activity 0.119 (0.087,0.151) 0.559 (0.140,0.979) 0.489 (0.075,0.903)
Pain 0.046 (0.017,0.074) -0.222 (-0.449,0.005) -0.221 (-0.443,0.002)
Appearance 0.020 (0.001,0.040) 0.020 (0.001,0.039) 0.023 (0.005,0.042)
Mental Health 0.037 (0.015,0.059) 0.035 (0.013,0.057) 0.037 (0.016,0.058)
(Function / activity)2 -0.050 (-0.097,-0.002) -0.042 (-0.089,0.005)
Pain2 0.031 (0.005,0.057) 0.031 (0.005,0.057)
Cobb angle 0.001 (0.001,0.002)
Goodness-of-fit
R2 59.3% 60.4% 62.1%
Adj R2 58.6% 59.3% 60.9%
AIC -536.647 -538.734 -546.650
BIC -519.567 -514.822 -519.321
Predictive performance
RMSE 0.073 0.072 0.071
MAE 0.053 0.052 0.052
AE > 0.05 40.9% 39.1% 39.1%
AE > 0.10 18.7% 16.4% 15.1%
Note: SRS-22r = Refined Scoliosis Research Society-22; AIC = Akaike information criteria; BIC = Bayesian information criteria; RMSE = root mean square
error; MAE = mean absolute error; AE = absolute error; C.I. = Confidence Interval; Coeff. = Coefficient
https://doi.org/10.1371/journal.pone.0175847.t004
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recognized for observed scores beyond 0.8. Table 5 depicted the predictive performance of
three models in the 10-fold cross-validation. In error analysis using cross-validation, RMSE
and MAE were between 0.063–0.065 and between 0.039–0.044, respectively. Validation results
of applying mapping models to AIS patients ascertained that models predicted the EQ-5D-5L
scores accurately. Therefore, model 3 was recommended out of three mapping models given
that the SRS-22r subscale scores and Cobb angle were available.
Discussion
AIS is the most common pediatric spinal deformity affecting both physical and mental health.
Treatment options involving observation, bracing and surgeries can impose various degrees of
burden onto patients.[5, 29–33] Such burdens can be induced by a concern of curvature pro-
gression depending on its initial magnitude and patients’ maturity status, aesthetic concern,
inconvenience of bracing during daily activities, as well as postoperative pain, and recovery for
surgical patients.[34, 35] It is demonstrated that AIS patients may experience psychosocial dif-
ficulties, especially those undergoing active treatment, as compared to adults with scoliosis,
who generally display fewer psychological problems.[35] Hence the varied quality of life of AIS
patients and their treatment outcome warrant an assessment, especially in terms of economic
evaluation in relation to different treatment options.
The SRS-22r questionnaire, being a disease-specific measure, is able to assess states and
concerns of this particular diagnostic groups, and may have more items concerning functions
most relevant to the disease.[36] However, such an instrument does not give the utility score
for comparison across different disease populations. Health state utility values are usually
based on generic instruments that permit comparisons between patient groups.[37] Therefore,
it is desirable to have an equivalent and widely used generic instrument, which is shown to be
successful in capturing the spine-specific questionnaire responses from AIS patients. The EQ-
5D is recommended and widely used in economic evaluation as required by the NICE.[38] It
has been most widely applied in recent years[39] as the EQ-5D is cognitively simple for self-
completion, and it is found to be the most commonly used instrument in most cost-utility
analysis studies conducted alongside clinical trials.[40] NICE states that ‘when EQ-5D data are
not available or are inappropriate for the condition or effects of treatment, the valuation meth-
ods should be fully described and comparable to those used for EQ-5D’.[38] In particular,
EQ-5D-5L was shown to have improved measurement properties and discriminatory power
with reduced ceiling effects as compared to EQ-5D-3L.[41] Hence, the mapping of SRS-22r
responses onto EQ-5D-5L score is required to enable an economic evaluation of treatment
outcomes of AIS patients.[42]
Table 5. Predictive performance of three models in 10-fold cross-validation.
Mapping Models for EQ-5D-5L scores
Model 1 Model 2 Model 3
Predictive performance
RMSE 0.065 0.062 0.063
MAE 0.044 0.039 0.039
AE > 0.05 32.8% 30.7% 30.3%
AE > 0.10 13.8% 11.7% 11.7%
Note: EQ-5D-5L = EuroQoL 5-dimension 5-level; RMSE = root mean square error; MAE = mean absolute
error; AE = absolute error
https://doi.org/10.1371/journal.pone.0175847.t005
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Regarding the pattern of overestimation for observed scores lower than 0.8, and underesti-
mation for observed scores beyond 0.8, there is a lower likelihood of being overestimated by
this mapping model because of ceiling effects of the EQ-5D-5L utility score. About two-third
(66%) respondents had a perfect health state of EQ-5D-5L, and thus those utility scores with
maximum score of 1.0 are impossible to be overestimated.
The development of our mapping model not only aims to establish statistical relationship
between EQ-5D-5L utility scores and scoliosis-specific SRS-22r domain scores, it also explores
the possibility of developing accurate but simple-to-use mapping models leveraging conver-
sion from existing SRS-22r data onto EQ-5D utility scores. It is mandatory to further investi-
gate the accuracy and reliability of such mapping models in their predictions for AIS, as well as
to ascertain the models’ suitability for this particular scoliotic group. SRS-22r dimension scores
therefore are mapped onto EQ-5D-5L scores using a number of different model specifications.
The predictive performance and goodness-of-fit indices of mapping models for AIS are evalu-
ated on a variety of treatment modalities, regardless of active observation, bracing or surgical
intervention.
There are three models developed in our attempt to seek the ability of mapping SRS-22r
onto EQ-5D-5L at its best extent. Notably, through the inclusion of not only the demographic
Fig 1. The scatterplot of observed and predicted EQ-5D-5L utility scores by mapping function. There was overestimation for more severe health
states when the observed EQ-5D-5L utility scores was smaller than 0.8. Underestimation was demonstrated for observed EQ-5D-5L utility scores beyond
0.8.
https://doi.org/10.1371/journal.pone.0175847.g001
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profiles, but with the four out of five possible SRS domain scores captured (Function/activity,
Pain, Self-image/Appearance, and Mental Health except Satisfaction with Treatment), the
model has improved from the base model to demonstrate an acceptable goodness-of-fit. By
further addition of socio-demographic characteristics like sex and age of patients, and explana-
tory variables such as Cobb angle at the time of presentation and treatment status, the final
model continues to offer improved model performance with good predictive performance and
a relatively constant MAE. The clinical relevance of this developed mapping model should be
emphasized, as the Cobb angle at the time of visit, the squared terms of ‘Function/activity’ and
‘Pain’ domain scores were found to be significant. These are variables which clinicians can
professionally assess and can find their relevance. Addition of squared terms of SRS-22r
domains provided evidence on the non-linear associations between spine-specific HRQOL
scores and health utility score. On the other hand, despite not being found at a significant level
statistically, aspects like patients’ perceived appearance and mental health may not be easily
gauged by clinicians, but they were successfully included in the development of this mapping
model.
The main limitation of this study relates to the Hong Kong value sets of EQ-5D-5L cur-
rently not being available until further social tariff of EQ-5D is developed. As this study being
the first to map between EQ-5D-5L and SRS-22r questionnaires and focused specifically onto
the local Chinese scoliosis population, no existing mapping function is available for compari-
son, and the mapping models generated can be population-specific. It will be ideal to have
comparative studies in other countries or ethnic groups, and variable health-care systems to
further validate our findings. A larger scale multi-center study of Chinese scoliosis patients can
be helpful to provide large sample sizes for further testing of the developed model. Also, it is
worth mentioning that the domain of treatment satisfaction of SRS-22r is not covered by EQ-
5D-5L. Self-image, as a disease-specific domain, is not included either in the EQ-5D-5L. How-
ever, the addition of clinical parameter based on Cobb angle is accounted for, hence the model
is only slightly undermined with good resultant predictive performance and goodness of fit
still.
Nonetheless, this is the first study to establish statistical models mapping a scoliosis-specific
HRQoL questionnaire onto a widely used generic utility score specifically for AIS patients.
Although there are currently no standards or thresholds of whether our mapping models are
adequately performed, they out-performed most of the published mapping models[43] in
terms of goodness-of-fit indices and predictive performance. The mapping process has been
perfected by incorporating scoliosis-specific clinical and demographic characteristics into the
model. Not only is the achieved mapping model feasible to be used in economic evaluation of
clinical research projects, this valid model has provided the basis for the ultimate assessment of
QALYs, a measure of health benefit enabling a standardized approach for comparing eco-
nomic evaluations across different healthcare areas.[13, 39]
Conclusion
Being able to employ EQ-5L-5D through mapping based on existing SRS-22r data allows com-
parison of AIS with other populations or disease groups, and more importantly enables health
economic appraisal for AIS patients, in terms of cost-utility of different treatment options,
patients’ quality of life resulting from treatment undergone and their QALY. As the impact of
a treatment on patients’ HRQoL and the impact on the length of life can both be encapsulated
by QALY, a summary measure of health outcome can then be derived. Based on such health
outcome, this will bring current assessment to a new phase in the aspect of clinical appraisal of
different scoliosis centers, and orientate their management approach towards more effective
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use of resources. This can alter healthcare resource allocation decisions and can potentially
reform healthcare policy on its largest scale. Moreover, this can bring a new perspective to the
decision making on individual treatment option and management of AIS patients in the
future.
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